Results 191 to 200 of about 106,373 (291)

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, Volume 20, Issue 9, Page 2296-2322, September 2026.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Robot-Assisted Partial Cystectomy in a 10-Year-Old: Managing a Rare Bladder Leiomyoma With Minimally Invasive Surgery. [PDF]

Cureus
Chu E, Press BH, Rodriguez MV, Kirsch AJ.   +3 more
europepmc   +1 more source

Targeted Delivery of Indole‐3‐Pyruvic Acid Suppresses Macrophage Ferroptosis to Enhance CD8+ T Cell‐Mediated Immunotherapy Response in Bladder Cancer

Advanced Science, Volume 13, Issue 53, 24 September 2026.
A microbiota‐derived metabolite, indole‐3‐pyruvic acid, suppresses macrophage ferroptosis through the AHR–NF‐κB–SLC7A11 axis. This preserves CD8+ T cell function in bladder cancer. Macrophage‐targeted nanoparticles enhance indole‐3‐pyruvic acid delivery and overcome resistance to PD‐1 blockade.
Jianwen Lao, Xinhao Yuan, Shuai Liang, Kai Deng, Daqin Wu, Longhao Xu, Kun Zheng, Yi Lin, Peicong Cai, Haoran Zheng, Junyu Chen, Mingli Luo, Yan Chen, Xiong Chen, Chunhui Wang, Wenlong Zhong   +15 more
wiley   +1 more source

Low diagnostic yield of routine preoperative chest CT in patients undergoing partial nephrectomy: A national cohort study using UroCCR data (UroCCR n°216)

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objective The aim of this study was to evaluate the diagnostic yield and downstream clinical impact of routine preoperative chest CT in patients undergoing partial nephrectomy (PN) for localized renal cell carcinoma. Methods We conducted a retrospective multicentre study using data from the French Urological Cancer Comprehensive Cohort (UroCCR)
Ali Bourgi, Gaëlle Margue, Pierre Bigot, Norbert De Brek, Louis Surlemont, Martin Lorette, Nicolas Branger, Thomas Prudhomme, Aurélien Adypagavane, Véra Chatain, Thibaut Waeckel, Alexis Fontenil, Victor Gaillard, Jean‐Jacques Patard, Constance Michel, Julien Guillotreau, Olivier Belas, Maxime Vallée, Stéphane De Vergie, Jean‐Baptiste Beauval, Clément Sarrazin, Benjamin Delattre, Frédéric Panthier, Lionel Hoquetis, Romain Boissier, Julien Anract, Marie Chicaud, Alexandre Marsaud, Richard Mallet, Quentin‐Côme Le Cerlc, Khalil Chalhoub, Idir Ouzaid, Jean‐Christophe Bernhard, Franck Bruyère   +33 more
wiley   +1 more source

Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial. [PDF]

Investig Clin Urol
Lee HW, Song G, Lee HH, Jung EH, Kim SY, Kim H, Park WS, Kwon J, Seo HK.   +8 more
europepmc   +1 more source

Salvage prostate therapies for local pelvic recurrence after primary radiation for prostate cancer

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objectives The purpose of this study is to evaluate salvage treatment after primary radiation therapy (RT) for prostate cancer within our hospital system. Specifically, we aim to evaluate treatment patterns, oncologic outcomes and complications.
Jamie Michael, Kathryn Fink, Vivian Wan, Sai K. S. R. Kaushik, Clayton Neill, Yutai Li, Ridwan Alam, David J. VanderWeele, Shilajit Kundu, Ashley E. Ross   +9 more
wiley   +1 more source

From feasibility to translational pathways: a bibliometric and knowledge-mapping analysis of urine-based liquid biopsy in urologic cancers (2015-2025). [PDF]

J Transl Med
Liu H, Fu Y, Yang J, Wang L, Bao J, Ding L, Shi W, Chen S, Li X.   +8 more
europepmc   +1 more source

Perioperative propranolol during robotic‐assisted radical prostatectomy: A randomised, double‐blind, placebo‐controlled, pilot trial (PeP‐RALP)

BJUI Compass, Volume 7, Issue 9, September 2026.
Abstract Objective This study aimed to determine the feasibility and safety of administering perioperative propranolol, as an adjunct to reduce prostate cancer recurrence, in patients undergoing robotic‐assisted laparoscopic prostatectomy (RALP) for European Association of Urology (EAU) intermediate‐ or high‐risk prostate cancer.
Shivanthe Sivanesan, Håkon Ramberg, Thomas Kristiansen, Suraj B. Thapa, Marthe Bjøre, Viktor Berge, Fredrik Ottosson, Bjørn Brennhovd, Anne M. H. Storås, Per M. Thorsby, Sandra R. Dahl, Alfonso Urbanucci, Helene Hartvedt Grytli, Lars Bjerke, Kristin Austlid Taskén   +14 more
wiley   +1 more source

Environmental Nonessential Element Exposure and Urologic Cancer: A Systematic Review and Meta-Analysis.

JAMA Netw Open
Deng Z, Li J, Ji R, Delgado JR, Yim SHL, Kachuri L, Cardenas A, Graff RE, Leppert JT, Dennis LK, Chung BI, Langston ME.   +11 more
europepmc   +1 more source

[Therapy of urologic neoplasms by interferons].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1986
openaire   +1 more source